Mehran Alizadeh Aghdam
6PUBLICATIONS
11CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|May 06, 2025
Spectrum and Impact of Reported Side Effects of Omalizumab in Patients With Chronic Urticaria: A Long-Term Multicentre Real-World Study.Reineke Soegiharto, Esther Van der Wind, Mehran Alizadeh Aghdam
|Oct 08, 2024
Omalizumab is effective and safe in chronic inducible urticaria (CIndU): Real-world data from a large multi-national UCARE study.R Soegiharto, M Alizadeh Aghdam, J A Sørensen
|Jul 15, 2022
Recombinant human C1 esterase inhibitor as prophylactic treatment in idiopathic non-histaminergic angioedema.Mehran Alizadeh Aghdam, Zonne L M Hofman, Michelle Meertens
|Jul 15, 2021
Systemic and local evidence for complement involvement in chronic spontaneous urticaria.Mehran Alizadeh Aghdam, Mignon van den Elzen, Harmieke van Os-Medendorp
|Dec 11, 2020
Safety and effectiveness of omalizumab for the treatment of chronic urticaria in pediatric patients.Coco Dekkers, Mehran Alizadeh Aghdam, Marlies de Graaf
|Jan 12, 2020
Response of FcεRI-bearing leucocytes to omalizumab in chronic spontaneous urticaria.Mehran Alizadeh Aghdam, Edward F Knol, Mignon van den Elzen
Pageof 1
Frequent Collaborators
2 joint publications
Reineke Soegiharto
2 joint publications
Heike Röckmann
1 joint publications
M Maurer
1 joint publications
R F J Criado
1 joint publications
A M Giménez-Arnau
1 joint publications
A Salman
1 joint publications
Edward F Knol
1 joint publications
Coco Dekkers
1 joint publications
Marlies de Graaf
1 joint publications
André C Knulst
